You just read:

COPD Asia-Pacific Market - Valued at $7.3 Billion in 2022 - Gradual Transition from ICS Therapies Toward Targeted and Triple Combination Drug Treatments - Research and Markets

News provided by

Research and Markets

30 Jan, 2017, 14:10 GMT